Fitusiran is a small interference RNA therapeutic designed to prevent bleeds in patients with hemophilia A or B by lowering antithrombin.

Sanofi's oral, reversible Bruton’s tyrosine kinase (BTK) inhibitor rilzabrutinib has gained US Food and Drug Administration ...

Yesterday the U.S. District Court for the Northern District of California granted summary judgment to FDA and drug ...

The high court’s ruling effectively bans flavored vape products because of concerns that they could appeal to kids.

Find out how to apply More on this subject Share With the Bachelor of Business Administration, particular emphasis is placed upon the knowledge and analytical skills required in business, with the ...